BTB Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$12.2M
- Investors
-
3
BTB Therapeutics General Information
Description
Developer of non-opioid medicines intended to use small-molecule compounds targeting RNA splicing for the treatment of diseases and cancer immunotherapy. The company utilizes a novel mechanism of action that promotes the secretion of endogenous opioids and offers a therapeutic drug for rare congenital diseases caused by abnormal splicing, enabling the medical industry to reduce illness, save lives, and lead to a harmonious society.
Contact Information
Website
www.btbtherapeutics.comCorporate Office
- 26281 Wyndemere Court
- Escondido, CA 92026
- United States
Corporate Office
- 26281 Wyndemere Court
- Escondido, CA 92026
- United States
BTB Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC (Series A) | 12-Aug-2026 | $12.2M | Completed | Clinical Trials - Phase 2 |
BTB Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1-NV | ||||||||
| Series A-1 | ||||||||
| Series A | 13,793,101 | $0.000010 | $0.29 | $0.29 | 1x | $0.29 | 33.33% |
BTB Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BTB Therapeutics Patents
BTB Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026143186-A1 | Compositions and methods for treating pruritus | Pending | 27-Dec-2024 |
BTB Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BTB Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kyoto Capital Partners (Japan) | Venture Capital | Minority | ||
| Kyoto University Innovation Capital | Venture Capital | Minority | ||
| SMBC Venture Capital | Corporate Venture Capital | Minority |
BTB Therapeutics FAQs
-
When was BTB Therapeutics founded?
BTB Therapeutics was founded in 2020.
-
Where is BTB Therapeutics headquartered?
BTB Therapeutics is headquartered in Escondido, CA.
-
What is the size of BTB Therapeutics?
BTB Therapeutics has 7 total employees.
-
What industry is BTB Therapeutics in?
BTB Therapeutics’s primary industry is Drug Discovery.
-
Is BTB Therapeutics a private or public company?
BTB Therapeutics is a Private company.
-
What is the current valuation of BTB Therapeutics?
The current valuation of BTB Therapeutics is .
-
What is BTB Therapeutics’s current revenue?
The current revenue for BTB Therapeutics is .
-
How much funding has BTB Therapeutics raised over time?
BTB Therapeutics has raised $12.2M.
-
Who are BTB Therapeutics’s investors?
Kyoto Capital Partners (Japan), Kyoto University Innovation Capital, and SMBC Venture Capital have invested in BTB Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
